Comparing the effects of Mycozin and Clotrimazole 1% creams on vaginal candidiasis: a triple-blinded randomized controlled trial
Abstract Clotrimazole 1% and Mycozin vaginal cream have been reported to be effective in relieving the symptoms of vulvovaginitis caused by Candida. The resistance to azole compounds, and the side effects of chemical drugs have been reported following azole therapy. It was hypothesized that Mycozin...
Saved in:
Main Authors: | Khadije Hajizadeh, Zahra Alivand, Vahideh Rahmani, Leila Mehrannia, Sanam Nami, Behrooz Shokouhi, Mojgan Mirghafourvand |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-84389-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Celastrol boosts fluconazole efficacy against vaginal candidiasis: in vitro and in vivo evidence
by: Fatma Al-zahraa A. Yehia, et al.
Published: (2025-01-01) -
Pathogenetic aspects and modern possibilities of therapy of vulvovaginal candidiasis
by: Margarita R. Rakhmatulina, et al.
Published: (2024-12-01) -
Lactic acid in the vaginal milieu modulates the Candida-host interaction
by: Diletta Rosati, et al.
Published: (2025-12-01) -
Effects of intravaginal curcumin gels combined with electroporation on vulvovaginal candidiasis
by: Yizhi Zhang, et al.
Published: (2025-01-01) -
In vitro photodynamic therapy of Candida albicans, the cause of vulvovaginal candidiasis, is enhanced by Bacillus and Enterococcus probiotics
by: Zeinab Ghanbari, et al.
Published: (2025-02-01)